Skip to main content
. 2017 Jul 28;7:6800. doi: 10.1038/s41598-017-06450-2

Table 2.

Logistic regression analyses of associations between creatinine-adjusted concentrations of phthalate metabolites and clinical pregnancy loss.

Phthalate T1 (n = 1073) T2 (n = 1074) T3 (n = 1073)
No. of loss (%) OR (95%CI) No. of loss (%) OR (95%CI)
MMP 42 (3.91) 31 (2.89) 0.73 (0.45,1.17) 36 (3.36) 0.85 (0.54,1.35)
MEP 26 (2.42) 43 (4.00) 1.73 (1.05,2.84) 40 (3.73) 1.62 (0.98,2.69)
MBP 29 (2.70) 34 (3.17) 1.19 (0.72,1.97) 46 (4.29) 1.59 (1.00,2.56)
MBzP 35 (3.26) 40 (3.72) 1.18 (0.74,1.89) 34 (3.17) 1.00 (0.61,1.61)
MEHP 34 (3.17) 35 (3.26) 1.04 (0.64,1.69) 40 (3.73) 1.20 (0.75,1.92)
MEOHP 28 (2.61) 33 (3.07) 1.24 (0.74,2.07) 48 (4.47) 1.70 (1.05,2.74)
MEHHP 22 (2.05) 38 (3.54) 1.77 (1.03,3.01) 49 (4.57) 2.26 (1.35,3.78)
ΣLMWP 28 (2.61) 37 (3.45) 1.35 (0.82,2.22) 44 (4.10) 1.60 (1.00,2.60)
ΣHMWP 28 (2.61) 32 (2.98) 1.16 (0.69,1.94) 49 (4.57) 1.74 (1.08,2.80)

Abbreviations: OR, odds ratio; CI, confidence interval; T1/2/3, the first/second/third tertile of phthalate concentrations. Adjusted for maternal age, education, parity and gestational weeks of urine collection.